english.prescrire.org > Prescrire International > N°194 - June 2018

n°194

June 2018

Issue Contents
Editorial

Free  Organised cervical cancer screening

p.143

New Products


Eluxadoline (Truberzi°) and irritable bowel syndrome

p.145-148
Insufficiently effective, like other anti­diarrhoeals

Human papillomavirus 9-valent vaccine ­(Gardasil 9°) and cervical cancer

p.148-150
A few cases of dysplasia prevented, but an increase in painful reactions

Ixazomib (Ninlaro°) in multiple myeloma after treatment failure

p.151-152
Continue to use established regimens

Heterozygous familial hypercholesterolaemia

p.153-154
Alirocumab: efficacy still not demonstrated for prevention of cardiovascular disease

INN Common stem: -begron

p.154

Adverse Effects


Antibiotics during infancy: a risk factor for obesity?

p.155-157

Inset. The intestinal flora: proven metabolic functions

p.156

Polystyrene sulfonate: reduction in the effects of numerous drugs

p.157-158

Drug-related restless legs syndrome

p.158

Free  Tropicamide eye drops: misuse

p.159

Free  Anti-TNF alpha and thiopurines: lymphoma

p.159

Reviews


Acute heart failure with dyspnoea

p.160-162
First-choice treatments

Multiple sclerosis

p.163
Fampridine, after a second look: unfavourable harm-benefit balance

Outlook


Free  Facts and Figures - The finances of Association Mieux Prescrire: 2017 Prescrire annual report

p.164-165

Palonosetron: why is the paediatric dose 6 times higher than the adult dose?

p.166-167

Masthead


Free  Masthead

p.142

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe